11 beta-hydroxysteroid dehydrogenase type 1: A new regulator of fetal lung maturation

S Hundertmark, A Dill, H Buhler, P. Stevens, K Looman, V Ragosch, J R Seckl, C Lipka

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Glucocorticoids (GCs) induce surfactant synthesis in the late fetal lung. Deficient GC action causes respiratory distress syndrome. 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) converts. inert cortisone (11-dehydrocorticosterone in rodents) into active cortisol (corticosterone), thus amplifying intracellular GC action. We investigated 11beta-HSD1 in the late fetal lung using the licorice-derived inhibitor, glycyrrhetinic acid (GE), in pregnant rats (day 13 of gestation until term). Control fetal mice and rats showed high 11beta-HSD activity in the late fetal lung; levels of plasma 11-dehydrocorticosterone were also high. Reduction/loss of pulmonary 11beta-HSD1 activity in GE-treated rats substantially impaired fetal lung maturation. Lungs from GE-exposed rats had lower surfactant protein-A (mRNA and protein) levels and reduced amniotic fluid lecithin/sphingomyelin ratios. There was a marked depletion of lung surfactant before and afterbirth, as, detected by both light and electron microscopy. The data emphasize the importance of 11beta-HSD1 in amplifying key GC-dependent maturational processes in the late fetal lung.

Original languageEnglish
Pages (from-to)537-544
Number of pages8
JournalHormone and Metabolic Research
Volume34
Issue number10
Publication statusPublished - Oct 2002

Fingerprint

Dive into the research topics of '11 beta-hydroxysteroid dehydrogenase type 1: A new regulator of fetal lung maturation'. Together they form a unique fingerprint.

Cite this